MedPath

Flecainide Acetate

Flecainide Acetate Tablets, USP Rx only

Approved
Approval ID

552ce99a-1195-4f53-971a-ad5874bba9d5

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 26, 2021

Manufacturers
FDA

A-S Medication Solutions

DUNS: 830016429

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Flecainide Acetate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code50090-2233
Application NumberANDA202821
Product Classification
M
Marketing Category
C73584
G
Generic Name
Flecainide Acetate
Product Specifications
Route of AdministrationORAL
Effective DateNovember 12, 2020
FDA Product Classification

INGREDIENTS (6)

FLECAINIDE ACETATEActive
Quantity: 100 mg in 1 1
Code: M8U465Q1WQ
Classification: ACTIB
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
HYDROGENATED COTTONSEED OILInactive
Code: Z82Y2C65EA
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Flecainide Acetate - FDA Drug Approval Details